|
|
A new surgical approach for pseudocyst of dorsal pancreas |
Cheng-Ji Tang a , # , Guo-Guang Li a , # , Chen-Lin Jiang b , Sha-Yong Peng a , Su-Lai Liu a , b , c , d , ∗ |
a Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Changsha 410005, China
b Central Laboratory of Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha 410005, China
c Hunan Engineering Research Center of Digital Hepatobiliary Medicine, Changsha 410005, China
d Hunan Key Laboratory for the Prevention and Treatment of Biliary Tract Diseases, Changsha 410005, China
∗ Corresponding author at: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Changsha 410005, China.
E-mail address: liusulai@hunnu.edu.cn (S.-L. Liu).
# Contributed equally. |
|
|
Abstract Pancreatic pseudocyst is a common complication of pancreatitis [ 1 ], and most (around 70%) pancreatic cysts are pseudocysts [ 2 ]. In terms of clinical manifestations, pseudocysts are most often asymptomatic. Treatment is not required for asymptomatic pancreatic pseudocysts, because they tend to be absorbed spontanously [ 3 ]. The probability of spontaneous regression of asymptomatic pseudocysts may be improved by a conservative approach involving bowel rest and parenteral nutrition. No drugs are available for the treatment of pancreatic cysts [ 1 ]. For symptomatic or growing pancreatic pseudocysts, surgery is often required [ 4 ]. A common and effective surgical approach is pancreatic pseudocystgastric/ jejunal anastomosis. However, it is very difficult for the treatment of dorsal pancreatic pseudocysts. The deep dorsal location, complex anatomical relationships and large blood vessels prevent the dorsal wall from anastomosing with the gastrointestinal tract. Our center applied T-tube bridging drainage to solve the problem of anastomosis between dorsal pancreatic pseudocyst and jejunum. From October 2021 to October 2023, 15 patients underwent this surgical approach at our center, and achieved favorable therapeutic outcome. Herein we reported one of the cases below.
|
|
|
|
|
[1] |
Zhou L, Zhu JQ, Kou JT, Xu WL, Lyu SC, Du GS, Yang HW, Wang JF, Hu XP, Yu CZ, Yuan CH, Han DD, Sang CQ, Li B, Gao J, Qi HZ, Wang LM, Lyu L, Liu H, Wu JY, Lang R, He Q, Li XL. Chinese expert consensus on quantitatively monitoring and assessing immune cell function status and its clinical application (2024 edition)[J]. Hepatobiliary Pancreat Dis Int, 2024, 23(6): 551-558. |
|
|
|
|